Characterization of Murine Lung Dendritic Cells Infected with Mycobacterium tuberculosis

ABSTRACT Lung dendritic cells were identified by immunohistochemistry in lung tissue sections from C57BL/6 mice. Following isolation from the lungs using CD11c magnetic beads, the flow cytometric analysis of I-Ab+ and CD11c+ cells indicated a mixed population of dendritic cells at different stages of maturation, with most expressing an immature phenotype. When cultured for 7 days with recombinant murine granulocyte-macrophage colony-stimulating factor, 99% of cells were CD11c+ and had a morphology typical of immature dendritic cells. These cells were negative for CD34, CD14, and CD8α antigens but expressed low levels of the myeloid marker F4/80 and moderate levels of MAC3. All expressed high levels of CD11a (LFA-1), CD11b (Mac1), and CD54 antigens, with low levels of class II major histocompatibility complex. Most cells expressed CD80 but only a small percentage of cells were positive for CD40 and CD86. Both overnight and 7-day cultures of lung dendritic cells were able to phagocytose Mycobacterium tuberculosis, and this was associated with the production of interleukin-12 and stimulation of both naı̈ve and immune T cells to produce gamma interferon.

[1]  I. Orme,et al.  NEW VACCINES AGAINST TUBERCULOSIS: The Status of Current Research * , 1999 .

[2]  H. Wilson,et al.  Identification of progenitor cells in long-term spleen stromal cultures that produce immature dendritic cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Pulendran,et al.  Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Abrams,et al.  Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. , 1993, Journal of immunology.

[5]  I. Orme.  Beyond BCG: the potential for a more effective TB vaccine. , 1999, Molecular medicine today.

[6]  B. Bloom,et al.  Vaccine visions and their global impact , 1998, Nature Medicine.

[7]  R. Steinman,et al.  Developmental regulation of MHC class II transport in mouse dendritic cells , 1997, Nature.

[8]  M. Lipscomb,et al.  Comparison of lung dendritic cells and B cells in stimulating naive antigen-specific T cells. , 1999, Journal of immunology.

[9]  M. de Boer,et al.  Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. , 1997, Blood.

[10]  P. Holt,et al.  Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. , 1994, Journal of immunology.

[11]  R. Kradin,et al.  The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen , 1995, The Journal of experimental medicine.

[12]  Antonio Lanzavecchia,et al.  Distinct patterns and kinetics of chemokine production regulate dendritic cell function , 1999, European journal of immunology.

[13]  Simon C Watkins,et al.  Activation of human dendritic cells following infection with Mycobacterium tuberculosis. , 1997, Journal of immunology.

[14]  F. Sallusto,et al.  Origin, maturation and antigen presenting function of dendritic cells. , 1997, Current opinion in immunology.

[15]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[16]  G. Kraal,et al.  Subpopulations of lymphoid and non-lymphoid cells in bronchus-associated lymphoid tissue (BALT) of the mouse. , 1988, Immunology.

[17]  J. Austyn.  New insights into the mobilization and phagocytic activity of dendritic cells , 1996, The Journal of experimental medicine.

[18]  I. Orme,et al.  Prospects for new vaccines against tuberculosis. , 1995, BioTechniques.

[19]  M. Colston,et al.  Mycobacterium tuberculosis‐activated dendritic cells induce protective immunityin mice , 2000, Immunology.

[20]  I. Orme,et al.  Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  H. Ploegh.  Dendritic Cells: Biology and Clinical Applications , 1999, Nature Medicine.

[22]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[23]  P. Holt,et al.  Brief Definitive Report Dendritic Cells Are Recruited into the Airway Epithelium during the Inflammatory Response to a Broad Spectrum of Stimuli , 2022 .

[24]  A. Pollard,et al.  Characterization of murine lung dendritic cells: similarities to Langerhans cells and thymic dendritic cells , 1990, The Journal of experimental medicine.

[25]  Ariza,et al.  The Intravenous Model of Murine Tuberculosis is Less Pathogenic Than the Aerogenic Model Owing to a More Rapid Induction of Systemic Immunity , 1999, Scandinavian journal of immunology.

[26]  A. McLellan,et al.  Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand‐dependent pathway , 1996, European journal of immunology.

[27]  I. Orme.  The immunopathogenesis of tuberculosis: a new working hypothesis. , 1998, Trends in microbiology.

[28]  B. Samten,et al.  Depressed CD40 Ligand Expression Contributes to Reduced Gamma Interferon Production in Human Tuberculosis , 2000, Infection and Immunity.